|
|
| Blue Peter Research Centre (BPRC) |
Clinical & Epidemiology division |
Team |
1. |
Dr. KV Krishna Moorthy, MBBS, MIPHA, Head, Clinical & Epidemiology Division |
|
2. |
Dr. Suman Jain, MBBS, DCH, Sr. Med.Officer |
3. |
Mr. Mohammed Ismail, , Sr. Lab Technician |
4. |
Mr. Syed Muzaffarullah, Physiotherapist |
| 5. |
Ms. T. Anuradha, Nursing Aide |
| 6. |
Ms. Manikyamma, Lab Attender |
| 7. |
Mr. K. Venkateshwar Reddy, BA, Driver |
| 8. |
Mr. G. Venkatesh, Lab Attender |
| |
|
| |
|
|
|
|
| |
BPRC receives self-reporting and referred patients with Leprosy, Tuberculosis, and HIV/AIDS etc who are provided diagnostic and specialized treatment services. BPRC also offers physiotherapy and Grade 1 & 2 Micro Cellular Rubber (MCR) footwear to its clients. With effect from 01 Apr 2001, BPRC and DLRC were included in the Directly Observed Treatment Short (DOTS) course programme for TB. DOTS therapy has been implemented in a population of 1 lakh from Ranga Reddy District. To date, 526 patients have been inducted for DOTS. State Government Officers have commented favorably on the BPRC DOTS Programme.
|
|
Clinical division is undertaking the treatment of Multi Drug Resistance in Tuberculosis as well as Thalidomide therapy for chronic ENL reactions in leprosy. |
Completed Research Studies |
1. |
Reference values for touch sensation threshold in healthy normal subjects using Semmes Weinstein monofilament kit. |
2. |
A study to compare the results of skin smear and skin biopsy and its impact on the management of leprosy. |
3. |
Leprosy in an infant |
4. |
Bacterial and fungal populations of plantar ulcers. |
| 5. |
Role of BCG in the prevention of leprosy. |
Ongoing research studies |
| 6. |
Reactions in leprosy – Role of thalidomide in controlling ENL reaction |
| 7. |
Relapses in leprosy |
| 8. |
Study of new cases – their type, present status, reason for coming to BPRC. |
| 9. |
Study of Category II patients – reasons of the discontinuation of anti tubercular treatment started earlier. |
|
| |
|
|
|
